For its third fiscal quarter (ending September 30), Barrett Business Services Inc (NASDAQ: BBSI) has reported a -72% decline in E.P.S. from $2.72 a year ago to $0.75 in the current quarter. For the latest […]
iRobot Corp (NASDAQ: IRBT) has reported E.P.S. of $-0.21 for its third fiscal quarter (ending September 30) versus $-2.86 for the same period a year ago — a decline of -93%. For the latest four […]
Nutrien Ltd (NYSE: NTR) has reported E.P.S. of $0.04 for its third fiscal quarter (ending September 30) versus $0.15 for the same period a year ago — a decline of -73%. For the latest four […]
Fair Isaac Corporation (NYSE: FICO) has reported earnings for its fourth fiscal quarter (ending September 30) of $5.54 versus $4.09 for the same period a year ago — an increase of 35%. For the latest […]
Celsius Holdings Inc (NASDAQ: CELH) has reported earnings for its third fiscal quarter (ending September 30) of $0.00 versus $0.92 for the same period a year ago. For the latest four quarters through September 30, […]
CVS Health Corp (NYSE: CVS) has reported earnings for its third fiscal quarter (ending September 30) of $0.07 versus $1.76 for the same period a year ago — a decline of -96%. E.P.S. were $3.95 […]
Brookfield Infrastructure Partne (NYSE: BIP) has reported a loss for its third fiscal quarter (ending September 30) of $-0.11 versus $0.23 for the same period a year ago — a decline of -148%. For the […]
Amicus Therapeutics Inc (NASDAQ: FOLD) has reported E.P.S. of $-0.02 for its third fiscal quarter (ending September 30) versus $-0.07 for the same period a year ago — a decline of -71%. For the latest […]
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) has reported earnings for its third fiscal quarter (ending September 30) of $0.20 versus a loss $-0.40 for the same period a year ago — a decline of -150%. For […]
Vishay Intertechnology Inc. (NYSE: VSH) has reported E.P.S. of $-0.14 for its third fiscal quarter (ending September 30) versus $0.47 for the same period a year ago — a decline of -130%. E.P.S. were $0.63 […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research